1Ralevic V, Burnstock G. Receptors for purines and pyrimidines [J].Pharmacol Rev, 1998,50(3):413-492.
2Moreau JL, Huber G. Central adenosine A2A receptors: an overview [J]. Brain Res Brain Res Rev, 1999,31:65-82.
3Dixon AK, Gubitz AK, Sirinathsinghji DJS, et al. Tissue distribution of adenosine receptor mRNAs in the rat[J]. British Jornal of Pharmacology, 1996,118:1461 - 1468.
4Scholl DJ, Wells JN. Serine and Alanine mutagenesis of the nine native Cysteine residues of the human A1 adenosine receptors[J]. Biochemical Pharmacology, 2000,60:1647 - 1654.
5Beukers MW, Dulk HD, Tilbury Erica WV, et al. Why are A2B receptor low-affinity adenosine receptors? Mutation of Asn 273 to Tyr increases affinity of human A2B receptors for 2-( 1-Hexynl)adenosine[J]. Mol Pharmacol, 2000,58(6): 1349 - 1356.
6Ferre S, Fredholm BB, Morelli M, et al. Adenosine -dopamine receptor-receptor interaction as an intergrative mechanism in the basal ganglia [J]. Trods Neurosci, 1997,20(10):482-487.
7Dixon DA, Fenix LA, Kim DM, et al. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for Schizophrenia: I. Adenosine agonist[J]. Ann Pharmacoth, 1999,33:480-488.
8Kull B, Ferre S, Arslan G, et al. Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese Hamster Ovary cells cotransfected with the two receptors[J]. Biochem Pharmacol, 1999,58:1035 - 1045.
9Ferre S, Torvinen M, Antoniou K, et al. Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably contransfected fibroblast cells[J]. J Biol Chem, 1998,273(8):4718-4724.
10Hillefors M, Hedlund P. B, Euler G. von. Effects of adenosine A2A reccptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain[J]. Biochem Pharmacol 1999,58:1961 - 1964.
